Neurobo Pharmaceuticals Inc (NRBO) has gained Tuesday morning, with the stock adding 34.75% in pre-market trading to 3.8. NRBO's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 141 out of 146 industries, the stock ranks higher than 0% of stocks. Neurobo Pharmaceuticals Inc has fallen 13.76% over the past month, closing at $2.96 on June 22. During this period of time, the stock fell as low as $2.73 and as high as $3.46. NRBO has an average analyst recommendation of Strong Buy. The company has an average price target of $16.00.
Neurobo Pharmaceuticals Inc has a Long-Term Technical rank of 2. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 98% of the market scoring higher. In the Biotechnology industry which is number 139 by this metric, NRBO ranks better than 9% of stocks.
Premarket Mover: Neurobo Pharmaceuticals Inc (NRBO) Up 34.75%
NRBO has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on NRBO!